55 Packer Packer M M Lessons learned from the DAPA-HF trial concerning the mechanisms of benefits of SGLT2 inhibitors on heart failure events in the contexto of other large-scale trials nearing completion Lessons learned from the DAPA-HF trial concerning the mechanisms of benefits of SGLT2 inhibitors on heart failure events in the contexto of other large-scale trials nearing completion Cardiovasc Diabet Cardiovasc Diabet 2019 2019 18 18 129 129 133 133. The gene discussed is SLC5A2; the disease is heart failure.